The Christie charity hosted its glamorous and star-studded annual ball on Saturday 18th March at the recently refurbished Principal hotel in Manchester city centre.
Supported by investment management company, Brooks Macdonald, the event raised £170,000 which will go towards funding the cost of a £600,000 advanced 3D intervention system which will be the first of its kind in Europe and will improve treatment and survival rates for patients.
This equipment will enable experts at The Christie to road map a patient’s entire body with incredibly accurate 3D images, and deliver cancer treatments extremely precisely through pinhole surgery.
Dr Jon Bell, consultant in interventional radiology at The Christie explains: “Interventional radiology uses high tech 3D imaging and enhanced pinhole surgery to treat cancer. Over the last five years The Christie has seen the number of patients requiring interventional radiology more than double. Radiologists use x-rays rather than cameras to enable them to deliver treatments to specific target sites.”
The new equipment has 3D imaging with advanced road-mapping software to ensure ever more accurate delivery of targeted chemotherapy and radiotherapy. Using the advanced 3D imaging for highly targeted surgery also means reduced radiation doses and quicker recovery rates for patients, leading to shorter stays in hospital for many of them.
“This equipment is crucial to our patients here at The Christie,” adds Dr Bell.
“The procedures we do are becoming more advanced and complex as technology improves, and this 3D technology means that patients will benefit from treatment they wouldn’t otherwise receive.”
Claire Bennison, Director – Head of Services and Product Development at Brooks Macdonald added: “We were extremely proud to support this year’s charity ball which has raised vital funds to continue the remarkable treatment and research that takes place at The Christie.”
Will Young headlined the event which was hosted by BBC Match of the Day 2 and 5 live Sport host, Mark Chapman. Young’s singing career took off when his first single became the fastest selling debut single in UK chart history in 2002. He has since had four UK number one albums and has accumulated multiple honours, including two BRIT Awards, an Ivor Novello Award and worldwide sales of over eight million albums.
Star of TV’s Bargain Hunt, Charles Hanson, conducted the auction on the night.
Emmerdale actress and new Key 103 presenter Gemma Atkinson joined Will and Mark along with her soap co-stars Laura Norton (who plays Kerry), Michelle Hardwick (Vanessa), Amy Walsh (Tracy) and Dominic Brunt (Paddy) who together form Emmerdale band Main Street, who also performed on the night.
Other famous attendees on the night included Coronation St favourites Tisha Merry (Steph Britton), Cherylee Houston (Izzy Armstrong), and Katie McGlynn (Sinead Tinker); as well as Hollyoaks’ Nicole Barber-Lane (Myra McQueen), David Kennedy (Dirk Savage) and former Hollyoaks actress and Strictly Come Dancing contestant, Ali Bastian and Sarah Jayne Dunne. Rio 2016 Olympic gold medallists Nicola White (hockey player) and Stephanie Slater (paralympian swimmer) also attended.
Host Mark Chapman, said: “Everyone knows The Christie and the phenomenal work they do. I know personally how special The Christie is as they are currently treating a member of my family, and so I was delighted to be asked to host the ball. It was an amazing night and we raised much needed funds for state of the art technology for cancer patients. I’m so impressed with everything they do that I’m also going to run the London marathon next month on their behalf.”
The Christie charity supports the work of The Christie NHS Foundation Trust through its fundraising activities, and delivers projects, equipment and improvements that are over and above what the NHS funds. The charity has over 43,000 supporters who helped raise £15.9m last year.
The Christie NHS Foundation Trust has been ranked ‘Outstanding’ by the health regulator the Care Quality Commission which referred to it as ‘exceptional’ and ‘a leader in its field’. It commended the Trust not only for its effectiveness and care, but highlighted its work in shaping the future of cancer care and noted the reach and influence of its clinical research projects.